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Abstract We performed a transmission study using mice
to clarify the characteristics of the most recent case of
scrapie in Japan. The mice that were inoculated with the
brain homogenate from a scrapie-affected sheep developed
progressive neurological disease, and one of the scrapie-
affected mice showed unique clinical signs during primary
transmission. This mouse developed obesity, polydipsia,
and polyuria. In contrast, the other affected mice exhibited
weight loss and hypokinesia. In subsequent passages, the
mice showed distinct characteristic scrapie phenotypes.
This ﬁnding may prove that different prion strains coexist
in a naturally affected sheep with scrapie.
Abbreviations
PrP
Sc Abnormal prion protein
CNS Central nervous system
Ka/O Kanagawa/scrapie obesity-type prion
Ka/W Kanagawa/scrapie weight-loss-type prion
mAb Monoclonal antibody
PrP Prion protein
PrPcore Proteinase-K-digested PrP
Sc
sCJD Sporadic Creutzfeldt–Jacob disease
TSE Transmissible spongiform encephalopathy
WB Western blotting
Scrapie is a transmissible spongiform encephalopathy
(TSE) that affects sheep and goats. It is characterized by
spongiform changes in the central nervous system (CNS)
and accumulation of an abnormal prion protein (PrP
Sc)i n
the CNS and lymphoid tissues; PrP
Sc is the major com-
ponent of prions [1]. Thus far, multiple strains of scrapie
prions have been identiﬁed [2–6]. These strains can be
distinguished on the basis of the incubation period, the
lesion proﬁle, and the pattern of the PrP
Sc accumulation in
the transmission studies with mice. The characteristic
phenotypes of these prion strains are conserved during
serial passage within a single host [2]. However, the
mechanism of emergence of prion strains is still unknown.
A 60-month-old Suffolk ewe developed ananastasia and
eventually died in Kanagawa prefecture, Japan, and it was
diagnosed as scrapie (Ka/scrapie). To clarify the biological
properties of prions in this most recent case of scrapie in
Japan, we examined the transmissibility of scrapie prions in
wild-type ICR mice (PrP allotype PrP
A/A; PrP
A encodes
PrP with leucine at codon 108 and threonine at codon 189;
Japan SLC, Inc., Japan) by using previously described
methods [7]. All of the mice that were inoculated with the
brain homogenate of scrapie-affected sheep developed
progressive neurological diseases; one of the disease-
affected mice exhibited unique clinical signs during pri-
mary transmission (Table 1). After an incubation period of
469 days, this mouse developed obesity, polydipsia, and
polyuria followed by slowness of movement; the prion
responsible for these symptoms is designated as the
Ka/scrapie obesity-type (Ka/O) prion. In contrast, after an
incubation period of 457 ± 21.1 days, the other disease-
affected mice (15) exhibited weight loss, hypokinesia, and
uncoordinated hind-limb movements; the prion responsible
for these symptoms was designated as the Ka/scrapie
weight-loss-type (Ka/W) prion. To further investigate the
K. Masujin and Y. Shu contributed equally to this work.
K. Masujin  Y. Shu  H. Okada  Y. Matsuura  Y. Iwamaru 
M. Imamura  S. Mohri  T. Yokoyama (&)
Prion Disease Research Center, National Institute of Animal
Health, 3-1-5 Kannondai, Tsukuba, Ibaraki 305-0856, Japan
e-mail: tyoko@affrc.go.jp
123
Arch Virol (2009) 154:1929–1932
DOI 10.1007/s00705-009-0534-2properties of these prions, brain homogenates from the
Ka/O- and Ka/W-affected mice were inoculated into wild-
type mice, and these mice were subjected to neuropatho-
logical and biochemical examinations. The mice that were
inoculated with the brain homogenate of the Ka/O-affected
mouse developed obesity, polydipsia, and polyuria after an
incubation period of 287.0 ± 6.5 days. Conversely, those
inoculated with the brain homogenate of the Ka/W-affected
mice exhibited weight loss and hind-limb ataxia after an
incubation period of 255.8 ± 28.2 days. Moreover, mice in
the subsequent Ka/O and Ka/W passage lines showed
different clinical signs, and the incubation periods of the
third passage lines in the Ka/O- and Ka/W-affected mice
were 272.3 ± 29.0 and 151 ± 5.6 days, respectively. The
body weights of the Ka/O- and Ka/W-affected mice at the
third passage are shown in Table 2.
Neuropathological examinations of these mice were
performed by using previously described methods [7].
Spongiform changes were detected throughout the brains of
both the Ka/W- and Ka/O-affected mice. The degree of
vacuolation in the brains of the Ka/W-affected mice was
moreseverethan thatintheKa/O-affected mice (Fig. 1a–c).
Immunohistochemical analyses were performed by using
previously described methods [7, 8]. The PrP
Sc types and
their distributions in the Ka/O- and Ka/W-affected mice
were different (Fig. 1d–g). Punctate and ﬁne granular PrP
Sc
were predominantly and uniformly distributed throughout
thebrainsoftheKa/W-affectedmice(Fig. 1d,f).Incontrast,
in the Ka/O-affected mice, coarse granular PrP
Sc was pre-
dominantly distributed in the thalamus, the brain stem, and
the cerebral cortex (Fig. 1e, g), while PrP plaques were
observed in the corpus callosum, the thalamus, and the
cerebral cortex (inset of Fig. 1e).
In recent studies, prion strains have been distinguished
on the basis of the biochemical properties of the PrP
Sc,
such as the glycoform ratio and the molecular mass of
proteinase-K-digested PrP
Sc (PrPcore) [9–13]. We charac-
terized the PrPcore molecules that had been extracted from
the brains of the Ka/O- and Ka/W-affected mice by using a
previously described method [14]. Western blotting (WB)
analysis revealed that the PrPcore obtained from the Ka/O-
and Ka/W-affected mice had similar glycoform patterns
and molecular mass (Fig. 2). These results indicate that
two strains of prions with distinct properties were isolated
from a single source, i.e., the brain of the scrapie-affected
sheep.
Different types of PrP
Sc (types 1 and 2) were reported to
co-exist in a case of sporadic Creutzfeldt–Jacob disease
(sCJD) [15]. Scrapie in sheep is also proposed to be caused
by mixed populations of different prion strains [16, 17]. In
the present study, different prion strains were isolated from
the brain of a scrapie-affected sheep during the primary
transmission studies. In the previously reported CJD case,
the PrPcore sizes of the two strains were different. In
contrast, in the case reported in this study, although their
PrPcore sizes were not different, the prions of the two
strains showed distinct biological characteristics. In addi-
tion, this result showed that a transmission study using
experimental animals is a useful approach for the isolation
and characterization of prion strains. New TSE strains are
believed to emerge due to mutations caused by differences
in the primary PrP sequences of the host and the inoculum
[17]. We observed that 3 out of 31 mice showed the
characteristic clinical signs of the Ka/O strain in repeat
trials of Ka/scrapie transmission (data not shown). This
data indicates that the Ka/O strain shows a constant
occurrence rate of 6–9%. Therefore, our ﬁndings may
indicate that mixed prion populations exist in a
Table 1 Transmission of Ka/scrapie in wild-type ICR mice
First passage (16/16
a) Second passage Third passage
15/16
b 457 ± 21.1
c ? 5/5 255.8 ± 28.8 ? 10/10 151.5 ± 5.6
1/16
d 469 ? 5/5 287.0 ± 6.5 ? 10/10 272.3 ± 29.0
a Number of infected mice/number of inoculated mice
b Mice exhibiting weight loss and hind-limb ataxia. All of these mice
showed the same clinical signs and same neuropathological phenotype.
The brain homogenate of 1 of the 15 mice was used for the second passage
(incubation period, 463 days)
c Average ± standard deviation (days)
d A single mouse exhibiting polydipsia, polyuria, and obesity
Table 2 Body weights of the Ka/W- and Ka/O-affected wild-type ICR mice
Inoculum
a Mouse numbers Weeks post-inoculation
0 1 2 2 02 8 3 23 6
Ka/W 6 12.3 ± 1.0
b 39.5 ± 7.8 36.2 ± 6.9*
Ka/O 6 12.5 ± 0.9 44.1 ± 3.8 56.8 ± 5.5* 68.8 ± 3.7** 68.6 ± 7.5* 61.4 ± 9.4
Control 6 12.6 ± 0.7 40.1 ± 6.4 47.5 ± 9.0 49.0 ± 9.0 46.2 ± 6.9 47.8 ± 8.9
The asterisks indicate statistically signiﬁcant differences between the scrapie-affected mice and the age-matched control mice (Student’s t test:
* p\0.05; ** p\0.001)
a Ka/scrapie weight-loss-type prion (Ka/W)- and Ka/scrapie obesity-type prion (Ka/O)-affected ICR mice at third passage were analyzed
b Average ± standard deviation (gram)
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becomes dominant during prion propagation in mice. Our
results suggested that the Ka/W strain was the dominant
strain in the brain of Ka/scrapie-affected sheep, while the
Ka/O strain seemed to be the less dominant strain, which
may have been inefﬁciently selected during interspecies
transmission.
In this study, we examined the biological characteristics
of prions in the most recent case of scrapie in Japan. On the
basis of our results, we conclude that multiple prion strains
coexist in a scrapie-affected sheep. To elucidate the
molecular epidemiology of prion diseases, further studies
should be conducted to clarify the mechanism underlying
the emergence of new prion strains.
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